Literature DB >> 1320055

Murine mucosal T cells have VIP receptors functionally distinct from those on intestinal epithelial cells.

A M Blum1, R Mathew, G A Cook, A Metwali, R Felman, J V Weinstock.   

Abstract

Reports suggest that vasoactive intestinal peptide (VIP) binds to lymphocytes and modulates immune responses. The intestines are richly innervated with VIP-producing nerves. Thus, VIP from nerves or other sources may participate in mucosal immunoregulation. To explore this hypothesis further, murine intestinal mucosal inflammatory cells were scrutinized for functional VIP receptors. An [125I]VIP competitive binding assay characterized VIP receptors. Unfractionated lamina propria inflammatory cells bound [125I]VIP specifically. This binding was abrogated by T cell depletion. The VIP receptor on lamina propria T cells was of a single class with a Kd of 9.08 x 10(-9) M. It bound PHI and other peptide analogs poorly. The intestinal epithelial cell had a high-affinity VIP receptor (Kd 4.17 x 10(-10) M) that bound one VIP analog with moderate affinity. Both VIP and ConA stimulated mucosal inflammatory cells to release interleukin-5 (IL-5). Mucosal inflammatory cells depleted of T cells did not release IL-5 in response to VIP or ConA. It is concluded that: (1) some murine mucosal T lymphocytes have VIP receptors that may be distinct from those displayed on mucosal epithelial cells; (2) VIP affects mucosal T lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320055     DOI: 10.1016/0165-5728(92)90179-o

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii.

Authors:  Débora M G Sant'Ana; Marcelo B Góis; Jacqueline N Zanoni; Aristeu V da Silva; Cleverton J T da Silva; Eduardo J A Araújo
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

2.  PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Authors:  Mathew L Thakur; Mohan R Aruva; Jean Gariepy; Paul Acton; Satish Rattan; Shyam Prasad; Eric Wickstrom; Abass Alavi
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

3.  PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.

Authors:  Kaijun Zhang; Mohan R Aruva; Nylla Shanthly; Christopher A Cardi; Satish Rattan; Chirag Patel; Christopher Kim; Peter A McCue; Eric Wickstrom; Mathew L Thakur
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

4.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation.

Authors:  Kaijun Zhang; Mohan R Aruva; Nylla Shanthly; Christopher A Cardi; Chirag A Patel; Satish Rattan; Gregory Cesarone; Eric Wickstrom; Mathew L Thakur
Journal:  Regul Pept       Date:  2007-07-06

5.  PKCε stimulation of TRPV1 orchestrates carotid body responses to asthmakines.

Authors:  Nicholas G Jendzjowsky; Arijit Roy; Mircea Iftinca; Nicole O Barioni; Margaret M Kelly; Brittney A Herrington; Frank Visser; Christophe Altier; Richard J A Wilson
Journal:  J Physiol       Date:  2020-12-04       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.